The IL-6R α chain controls lung CD4⁺CD25⁺ Treg development and function during allergic airway inflammation in vivo

Original citation: J. Clin. Invest.115:313–325 (2005). doi:10.1172/JCI22433

Citation for this corrigendum: J. Clin. Invest.115:1388 (2005). doi:10.1172/JCI22433C1

Aysefa Doganci,¹ Tatjana Eigenbrod,¹ Norbert Krug,² George T. De Sanctis,³ Michael Hausding,¹ Veit J. Erpenbeck,² El-Bdaoui Haddad,² Hans A. Lehr,⁴ Edgar Schmitt,⁵ Tobias Bopp,⁵ Karl-J. Kallen,⁶ Udo Herz,⁷ Steffen Schmitt,⁸ Cornelia Luft,¹ Olaf Hecht,² Jens M. Hohlfeld,² Hiroaki Ito,⁹ Norihiro Nishimoto,⁹ Kazuyuki Yoshizaki,¹⁰ Tadamitsu Kishimoto,¹⁰ Stefan Rose-John,⁶ Harald Renz,⁷ Markus F. Neurath,¹¹ Peter R. Galle,¹¹ and Susetta Finotto¹

¹Laboratory of Cellular and Molecular Immunology of the Lung, First Medical Clinic, University of Mainz, Mainz, Germany. ²Fraunhofer Institute of Toxicology and Experimental Medicine, Hannover, Germany. ³Respiratory Pharmacology Department, Aventis Pharmaceuticals, Bridgewater, New Jersey, USA. ⁴Department of Pathology and ⁵Institute of Immunology, University of Mainz, Mainz, Germany. ⁶Institute of Biochemistry, University of Kiel, Kiel, Germany. ⁷Department of Clinical Chemistry and Molecular Diagnostics, University of Marburg, Marburg, Germany. ⁸FACS Core Facility, Department of Toxicology, University of Mainz, Mainz, Germany. ⁹Department of Host Defence, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan. ¹⁰Department of Molecular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan. ¹¹Laboratory of Immunology, First Medical Clinic, University of Mainz, Mainz, Germany.

H.A. Lehr’s present address is: Institute Universitaire de Pathologie, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland

The authors regret this error.